Risk factors for peripheral arterial disease among patients with chronic kidney disease

Jing Chen1, Emile R Mohler, Dawei Xie

  • 1Tulane University School of Medicine, New Orleans, LA, USA. jchen@tulane.edu

Insights

Patients with chronic kidney disease (CKD) face higher risks of peripheral arterial disease (PAD). Novel factors like inflammation, insulin resistance, and cystatin C are linked to PAD prevalence in CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) significantly elevates the risk of developing peripheral arterial disease (PAD).
  • Understanding novel risk factors associated with PAD in CKD patients is crucial for early detection and intervention.

Purpose of the Study:

  • To investigate the cross-sectional association between various novel risk factors and the prevalence of PAD in a large cohort of CKD patients.
  • To identify specific biomarkers and conditions contributing to PAD development in individuals with impaired kidney function.

Main Methods:

  • Analysis of 3,758 patients from the Chronic Renal Insufficiency Cohort (CRIC) study with estimated glomerular filtration rates between 20-70 ml/min/1.73 m(2).
  • Peripheral arterial disease (PAD) was defined by ankle-brachial index <0.9 or history of revascularization.
  • Statistical models adjusted for traditional risk factors, including age, gender, race, smoking, hypertension, diabetes, and lipid profiles.

Main Results:

  • Several novel risk factors demonstrated significant associations with prevalent PAD after multivariable adjustment.
  • Elevated levels of high-sensitivity C-reactive protein, white blood cell count, fibrinogen, uric acid, glycosylated hemoglobin, insulin resistance (HOMA-IR), and cystatin C were independently linked to PAD.
  • Odds ratios for a 1-SD increase in these factors ranged from 1.11 to 1.35, indicating increased PAD risk.

Conclusions:

  • Inflammation, prothrombotic state, oxidative stress, insulin resistance, and elevated cystatin C are associated with a higher prevalence of PAD in CKD patients.
  • These findings highlight potential targets for risk stratification and therapeutic strategies in managing PAD within the CKD population.
  • Further research is needed to establish causality and explore interventions targeting these novel risk factors.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...